Reiterates Compelling Strategic and Financial Benefits for Teva and Mylan Stockholders
Highlights Strength of Teva’s Business, Pipeline, Leadership and Long-Term Growth Prospects
JERUSALEM, May 6 (Bernama-BUSINESS WIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)(TASE:TEVA) today announced that an updated investor presentation in connection with its proposed combination with Mylan N.V. (NASDAQ: MYL) is available on the Investor Relations section of the Company’s website and will be filed with the Securities and Exchange Commission (“SEC”).
No comments:
Post a Comment